The supplement industry is sitting on a $209.5 billion market in 2025, on track to reach $431.7 billion by 2033. That's a 9.5% compound annual growth rate, and it sounds like a rising tide lifting all boats. It isn't. The growth is highly concentrated, and if you're still leading with pills and capsules, you're competing for a shrinking share of consumer attention while format-native brands absorb the upside.
According to September 2026 market data, gummies, liquid shots, and functional beverages are outpacing traditional tablet and capsule formats by a significant margin. The shift isn't subtle anymore. It's structural, and the brands treating it as a trend rather than a strategic inflection point are already falling behind.
The Market Is Growing. Your Segment May Not Be.
When aggregate numbers look this strong, it's easy to assume your category is healthy. But the $431.7 billion projection is being driven disproportionately by format innovation, not ingredient novelty. Functional beverages, gummy vitamins, and dissolvable liquid formats are pulling consumer dollars that would have defaulted to traditional supplements five years ago.
This matters for your brand positioning because the competitive threat isn't coming from a better magnesium formula or a superior B-vitamin complex. It's coming from a brand that packaged a comparable formula into a format consumers actually enjoy taking every day. Retention is the business model, and format is the retention mechanism.
If you want broader context on where supplement capital is concentrating right now, Sports Nutrition Hits $93.8B in 2026: Where the Money Is maps the specific segments attracting the most institutional attention this year.
Venture Capital Is Betting on Format, Not Formula
The WHO's 2023 Global Action Plan on non-communicable diseases didn't just shift public health policy. It catalyzed a wave of institutional capital into the preventive nutrition space. Investors who were previously skeptical of supplement brands as defensible businesses are now writing large checks into personalized nutrition startups that combine novel delivery systems with data-driven formulation.
These aren't incremental bets. Significant venture funding is flowing into companies that have built their identity around the delivery experience first and the ingredient stack second. The underlying thesis is that consumer behavior is sticky when the format removes friction, and that stickiness converts into subscription revenue, which is what acquirers actually want to buy.
The Nix Biosensors fundraise is a useful data point here. As covered in Nix Biosensors Closes $10M Series A to Scale Hydration Tech, the investment thesis centered on personalized physiological data intersecting with real-time supplementation decisions. That's the direction institutional money is moving: format plus personalization plus data, not a better capsule.
For operators who don't have VC backing, this creates a specific strategic problem. You can't out-ingredient a well-funded startup with a patent portfolio. But you can out-format them if you move quickly, because format innovation at the brand level doesn't require the same capital intensity as ingredient IP development.
Palatability Is a Retention Strategy
Here's a number that should reframe how you think about format: consumer adoption of daily supplementation habits is significantly higher when the product is palatable and portable. That's not a wellness blog observation. It's showing up in purchase behavior data and subscription churn metrics across the category.
The intersection of rising demand for natural and plant-based supplements with the format shift is particularly important. Consumers who are drawn to clean-label products are also the consumers most likely to abandon a routine when it feels medicinal or inconvenient. Gummies and liquid shots don't just appeal to these consumers on the first purchase. They keep them coming back.
Retention is where the economics of supplement brands either work or don't. A consumer who takes a gummy every morning because it fits into a habit loop has a fundamentally different lifetime value profile than one who keeps a capsule bottle in a cabinet and forgets about it for three weeks at a time. Format determines which consumer you're serving.
This connects to a broader point about how consumers are building wellness routines now. The same behavioral patterns driving format preference in supplements are influencing how people structure workouts, recovery, and daily health habits. Understanding sensory experience as a driver of habit formation, as explored in Sensory Priming: The Mental Hack for Better Workouts, is increasingly relevant to how supplement brands design the consumption experience itself.
Magnesium as a Case Study in Format-Driven Premiumization
Magnesium is a commodity ingredient. It's been in supplement formulas for decades, it's widely available, and there's no proprietary angle on the molecule itself. It's also identified in 2026 market data as one of the fastest-growing ingredient categories in the supplement space. That's not a contradiction. It's proof of concept for the format-first strategy.
What's happening with magnesium right now is instructive. Brands are repositioning a commodity input through delivery format, targeting consumer demographics that would never have considered a magnesium tablet. Magnesium gummies marketed for sleep quality are reaching consumers in their 30s and 40s who identify as wellness-conscious but not supplement-literate. Magnesium liquid shots are hitting the sports recovery segment. Magnesium functional beverages are landing in the calm and stress-reduction category.
Same ingredient. Three different consumer segments. Three different price points. The differentiation is entirely format-driven, and the margins on the gummy or the liquid shot are substantially better than on the tablet because the perceived value is higher and the positioning is cleaner.
This is the template. If magnesium can be premiumized through format innovation, the same logic applies to vitamin D, omega-3s, collagen, and the majority of the ingredient stack that most mid-market supplement brands are currently selling in pill form at thin margins.
The Strategic Math for Brand Operators
The ROI case for format reformulation over new ingredient development is straightforward once you lay it out. Developing a novel ingredient stack requires sourcing, clinical validation, regulatory navigation, and marketing education spend to explain what the ingredient does. The payback period is long, and the risk of the category not developing the way you projected is real.
Reformulating an existing product into a gummy, a liquid shot, or a functional beverage leverages your existing brand equity, your existing ingredient sourcing relationships, and your existing customer base. You're not asking anyone to understand a new ingredient. You're giving them a reason to stay with you instead of moving to a format-native competitor who's already taken the format step.
The consolidation dynamic reinforces this. As larger acquirers move through the supplement market, what they're buying is either proprietary ingredient IP or proven consumer retention. If you don't have the former, you need to build the latter. Format is the fastest path to retention metrics that make your brand attractive in an acquisition conversation.
For a detailed breakdown of where liquid formats specifically are gaining ground and what the brand strategy implications look like, The $209B Supplement Market: Why Liquid Formats Are Winning covers the competitive landscape with more granularity than most operators are currently working with.
What This Means for Your Brand Right Now
If you're operating a supplement brand in 2025 and 2026, the questions you need to be asking are format-first. Which of your current products has the highest repeat purchase rate? What format is it in? If it's a capsule or tablet, you have a retention ceiling that a format shift could raise. If it's already a gummy or a liquid, you need to ask whether your format experience is differentiated enough to hold position as better-funded competitors enter the same space.
The brands that are going to disproportionately capture the growth between here and $431.7 billion are not necessarily the ones with the most sophisticated formulas. They're the ones that understand format as a consumer relationship tool, not just a packaging decision.
- Audit your current line for format-format mismatches: Where are you selling a compelling ingredient in a low-engagement format?
- Identify your highest-retention SKUs: What format characteristics do they share? That's your reformulation template.
- Map the demographic shift: Which consumer segments are growing fastest in your category, and what formats are they already using in adjacent categories?
- Model the margin impact: Gummies and liquid shots typically command a price premium over tablets. Run the numbers on what a format shift does to your unit economics before you assume it's a cost problem.
- Think about acquisition readiness: If you're building toward an exit, retention data and subscription metrics matter more than formula complexity. Format drives both.
The supplement market's trajectory is not going to slow down. But the brands that benefit from that trajectory are already making format decisions now. The pill isn't going away entirely, but it's no longer the default, and defaulting to it is a strategic choice with measurable consequences. You have the market data. The next move is yours.